Summit Therapeutics PLC (LON:SUMM)

Summit Therapeutics PLC (LON:SUMM)


Share Price
31.00 p
Change
0 (0.00 %)
Market Cap
£49.72 m
Proactive Investors - Run By Investors For Investors

Summit Therapeutics PLC

Summit Therapeutics is a leader in antibiotic innovation. Summit’s new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers. The company is currently developing new mechanism antibiotics for infections caused by C. difficile, N. Gonorrhoeae and ESKAPE pathogens and is using its proprietary...

EPIC: SUMM
Market: AIM:SUMM
52-week High/Low: 209.00p / 9.50p
Sector: Pharma & Biotech
Market Cap: £49.72 m
Website: www.summitplc.com
col 3
col 4
col 5
col 6

Summit Therapeutics PLC RNS Announcements

Date Epic Announcement
27/12/2017 SUMM Acquisition of Discuva Ltd
23/03/2009 SUMM Summit Corporation PLC - Directorate change
23/03/2009 SUMM Summit Corporation PLC - Statement re Appointment of Interim Chief Financial..
20/02/2009 SUMM Summit Corporation PLC - Update on Financial Position
23/01/2009 SUMM Summit Corporation PLC - Directorate change
06/01/2009 SUMM Summit Corporation PLC - Licensing Agreement
22/08/2008 SUMM Summit Corporation PLC - Directorate change
22/07/2008 SUMM Summit Corporation PLC - Issue of Equity: Application to AIM
22/07/2008 SUMM Summit Corporation PLC - Re Agreement with BioMarin to develop DMD candidate..
09/07/2008 SUMM Summit Corporation PLC - AGM Statement
18/06/2008 SUMM Summit Corporation PLC - Notice of AGM
03/06/2008 SUMM Summit Corporation PLC - Final Results
01/05/2008 SUMM Summit Corporation PLC - Notice of Preliminary Results for Year ended 31..
29/04/2008 SUMM Summit Corporation PLC - Research Update - New Positive Data from DMD Programme
15/04/2008 SUMM Summit Corporation PLC - Positive results from Phase I clinical trial in acne
01/04/2008 SUMM Summit Corporation PLC - Total voting rights
25/03/2008 SUMM Summit Corporation PLC - Additional Listing
21/02/2008 SUMM Summit Corporation PLC - Re Contract
05/02/2008 SUMM Summit Corporation PLC - PAYMENT OF NON-EXECUTIVE DIRECTORS' FEES IN SHARES
16/01/2008 SUMM Summit Corporation - Start of Ph II clinical trial
06/12/2007 SUMM Summit Corporation - Change of Adviser
05/11/2007 SUMM Summit Corporation - Director/PDMR Shareholding
30/10/2007 SUMM Summit Corporation - Re Agreement
30/10/2007 SUMM Summit Corporation - Interim Results
25/10/2007 SUMM Summit Corporation - Holding in Company
23/10/2007 SUMM Summit Corporation - Clinical Update
12/10/2007 SUMM Summit Corporation - Notice of Results
02/10/2007 SUMM Summit Corporation - Research Donation
29/08/2007 SUMM Summit Corporation - Director/PDMR Shareholding
28/08/2007 SUMM Summit Corporation - Director/PDMR Shareholding

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use